RAPping production of type I interferon in pDCs through mTOR.
about
From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerInhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E PathwayCrystal structures of S6K1 provide insights into the regulation mechanism of S6K1 by the hydrophobic motifRecent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functionsVesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.The mucosal expression pattern of interferon-ε in rhesus macaquesRapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replicationProduction of interferon α by human immunodeficiency virus type 1 in human plasmacytoid dendritic cells is dependent on induction of autophagyAre reactive oxygen species always detrimental to pathogens?Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndromeSrc family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses.Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells.The PI3K Pathway in Human Disease.
P2860
Q26822694-13C38F7B-0F61-4B3E-A5E3-162821854E41Q27318237-95757216-39C2-4A02-B0AD-CB8F06FAC359Q27684745-2DEC9125-9023-4C66-963A-8D4B7CDDA26CQ30252210-6F98C5F8-D878-48E2-A0E0-04F323CA6128Q33667768-E2AC9CCD-5FCA-4755-A56A-46E62774C31EQ34484099-584F59AA-54B4-4E22-ADDA-6274C7D0EDE3Q35097829-371471D4-BF91-4E88-A0A4-35F34B90C147Q35842310-749B7E3A-3377-484E-8E32-49EA34F19531Q37584947-D1CE3B5D-EC25-43FF-8916-9312B1D67AAAQ37688819-CB75AB2F-3C30-4AB6-BCDA-17B96C98036CQ37739211-AC260FCB-A57C-497B-8C0A-72C8CA3B0AF8Q39021610-E89ACBD2-71B6-405B-8F2D-9B5E3B062BC5Q39109430-FD99839A-1653-4FAB-8F76-17A76BCE64BDQ40160550-415BD0D3-94CD-4549-BC07-90395C183692Q41237384-F014D05B-E44E-48E6-BF0D-7E227BE0FE05Q46546002-240CCE2C-6678-4A9F-912E-9EA0578FA975
P2860
RAPping production of type I interferon in pDCs through mTOR.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RAPping production of type I interferon in pDCs through mTOR.
@en
RAPping production of type I interferon in pDCs through mTOR.
@nl
type
label
RAPping production of type I interferon in pDCs through mTOR.
@en
RAPping production of type I interferon in pDCs through mTOR.
@nl
prefLabel
RAPping production of type I interferon in pDCs through mTOR.
@en
RAPping production of type I interferon in pDCs through mTOR.
@nl
P2860
P356
P1433
P1476
RAPping production of type I interferon in pDCs through mTOR.
@en
P2093
Mauro Costa-Mattioli
P2860
P2888
P304
P356
10.1038/NI1008-1097
P407
P577
2008-10-01T00:00:00Z
P6179
1033156741